| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |